ApothéCure and FDA notified all healthcare professionals of recent deaths associated with the use of compounded injectable Colchicine 0.5mg/ml, 4ml vials, lot number 20070122@26. The company issued an immediate drug recall for all strengths, sizes and lots of compounded Injectable Colchicine sold within the last year. Customers are asked to examine their stock for ApothéCure compounded Colchicine on hand and to discontinue use immediately and prepare the product for return to the company.
I will elaborate on this later today. Briefly, colchicine is a anti cancer drug that stabilizes microtubules to keep cells from dividing.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment